Faeth Therapeutics, Inc (FTH)

Faeth Therapeutics witnessed significant insider activity recently. CFO Brian C. Stephenson executed multiple share purchases throughout late June and early July. Conversely, Cambrian BioPharma Inc, a major stockholder, filed a proposed sale of 130,142 shares valued at approximately $3.6 million on July 22, following the company's latest earnings report.
Ticker: FTH Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Faeth Therapeutics, Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.8
Cambrian BioPharma Inc 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
431.72
Quantity 60,616
Value US$3,429,405
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
353.15
Quantity 56,525 -12.4%
Value US$575,475
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
171.61
Quantity 6,825 -44.4%
Value US$1,529,862
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
24.98
Quantity 4,255 +11.4%
Value US$106,290
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
23.88
Quantity 1,638 +4.6%
Value US$39,115
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
22.95
Quantity 1,910 +5.6%
Value US$43,834
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
23.34
Quantity 831 +2.5%
Value US$19,396
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
26.39
Quantity 100 +0.3%
Value US$2,639
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
25.55
Quantity 1,358 +4.3%
Value US$34,697
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
24.90
Quantity 4,212 +15.4%
Value US$104,879
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
23.61
Quantity 580 +2.2%
Value US$13,694
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
27.77
Quantity 100 +0.4%
Value US$2,777
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
26.98
Quantity 3,400 +14.6%
Value US$91,732
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
25.98
Quantity 3,000 +14.8%
Value US$77,940
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
25.22
Quantity 2,891 +16.6%
Value US$72,911
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
25.91
Quantity 425 +2.5%
Value US$11,012
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
24.84
Quantity 1,969 +13.1%
Value US$48,910
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
24.12
Quantity 6,836 +83.5%
Value US$164,884
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
23.95
Quantity 356 +4.5%
Value US$8,526
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
23.28
Quantity 3,329 +74.0%
Value US$77,499
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
22.40
Quantity 1,583 +54.3%
Value US$35,459
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
20.82
Quantity 1,118 +62.2%
Value US$23,277
2.0
STEPHENSON BRIAN C Chief Financial Officer Officer
Transaction date
Purchase
Price
20.23
Quantity 1,797 +inf%
Value US$36,353
Parikh Anand Kiran President and CEO Executive Director
Transaction date
Purchase
Price
19.76
Quantity 2,806 +0.4%
Value US$55,447
1.7
Peyer James See remarks below Large shareholder
Transaction date
Sale
Price
21.14
Quantity 476 -0.4%
Value US$10,063
1.7
Peyer James See remarks below Large shareholder
Transaction date
Sale
Price
20.00
Quantity 24,524 -15.8%
Value US$490,480
1.8
Cambrian BioPharma Inc Large shareholder
Transaction date
Sale
Price
21.14
Quantity 476 -0.4%
Value US$10,063
1.8
Cambrian BioPharma Inc Large shareholder
Transaction date
Sale
Price
20.00
Quantity 24,524 -15.8%
Value US$490,480
1.8
Cambrian BioPharma Inc 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
31.95
Quantity 155,142
Value US$4,956,786
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-11 2026-07-22 PrS Proposed sale

10% Stockholder

Large shareholder
60,616
431.72
US$3,429,405
60,616 431.72 US$3,429,405
2026-07-01 2026-07-01 B Purchase

Chief Financial Officer

Officer
56,525 -12.4%
353.15
US$575,475
56,525 -12.4% 353.15 US$575,475
2026-07-01 2026-07-01 B Purchase

Chief Financial Officer

Officer
6,825 -44.4%
171.61
US$1,529,862
6,825 -44.4% 171.61 US$1,529,862
2026-07-01 2026-06-30 B Purchase

Chief Financial Officer

Officer
4,255 +11.4%
24.98
US$106,290
4,255 +11.4% 24.98 US$106,290
2026-07-01 2026-06-30 B Purchase

Chief Financial Officer

Officer
1,638 +4.6%
23.88
US$39,115
1,638 +4.6% 23.88 US$39,115
2026-07-01 2026-06-30 B Purchase

Chief Financial Officer

Officer
1,910 +5.6%
22.95
US$43,834
1,910 +5.6% 22.95 US$43,834
2026-07-01 2026-06-29 B Purchase

Chief Financial Officer

Officer
831 +2.5%
23.34
US$19,396
831 +2.5% 23.34 US$19,396
2026-06-26 2026-06-26 B Purchase

Chief Financial Officer

Officer
100 +0.3%
26.39
US$2,639
100 +0.3% 26.39 US$2,639
2026-06-26 2026-06-26 B Purchase

Chief Financial Officer

Officer
1,358 +4.3%
25.55
US$34,697
1,358 +4.3% 25.55 US$34,697
2026-06-26 2026-06-26 B Purchase

Chief Financial Officer

Officer
4,212 +15.4%
24.90
US$104,879
4,212 +15.4% 24.90 US$104,879
2026-06-26 2026-06-26 B Purchase

Chief Financial Officer

Officer
580 +2.2%
23.61
US$13,694
580 +2.2% 23.61 US$13,694
2026-06-26 2026-06-24 B Purchase

Chief Financial Officer

Officer
100 +0.4%
27.77
US$2,777
100 +0.4% 27.77 US$2,777
2026-06-26 2026-06-24 B Purchase

Chief Financial Officer

Officer
3,400 +14.6%
26.98
US$91,732
3,400 +14.6% 26.98 US$91,732
2026-06-26 2026-06-24 B Purchase

Chief Financial Officer

Officer
3,000 +14.8%
25.98
US$77,940
3,000 +14.8% 25.98 US$77,940
2026-06-26 2026-06-24 B Purchase

Chief Financial Officer

Officer
2,891 +16.6%
25.22
US$72,911
2,891 +16.6% 25.22 US$72,911
2026-06-24 2026-06-23 B Purchase

Chief Financial Officer

Officer
425 +2.5%
25.91
US$11,012
425 +2.5% 25.91 US$11,012
2026-06-24 2026-06-23 B Purchase

Chief Financial Officer

Officer
1,969 +13.1%
24.84
US$48,910
1,969 +13.1% 24.84 US$48,910
2026-06-24 2026-06-23 B Purchase

Chief Financial Officer

Officer
6,836 +83.5%
24.12
US$164,884
6,836 +83.5% 24.12 US$164,884
2026-06-24 2026-06-22 B Purchase

Chief Financial Officer

Officer
356 +4.5%
23.95
US$8,526
356 +4.5% 23.95 US$8,526
2026-06-24 2026-06-22 B Purchase

Chief Financial Officer

Officer
3,329 +74.0%
23.28
US$77,499
3,329 +74.0% 23.28 US$77,499
2026-06-24 2026-06-22 B Purchase

Chief Financial Officer

Officer
1,583 +54.3%
22.40
US$35,459
1,583 +54.3% 22.40 US$35,459
2026-06-24 2026-06-22 B Purchase

Chief Financial Officer

Officer
1,118 +62.2%
20.82
US$23,277
1,118 +62.2% 20.82 US$23,277
2026-06-24 2026-06-22 B Purchase

Chief Financial Officer

Officer
1,797 +inf%
20.23
US$36,353
1,797 +inf% 20.23 US$36,353
2026-06-24 2026-06-22 B Purchase

President and CEO

Executive Director
2,806 +0.4%
19.76
US$55,447
2,806 +0.4% 19.76 US$55,447
2026-06-01 2026-06-01 S Sale

See remarks below

Large shareholder
476 -0.4%
21.14
US$10,063
476 -0.4% 21.14 US$10,063
2026-06-01 2026-06-01 S Sale

See remarks below

Large shareholder
24,524 -15.8%
20.00
US$490,480
24,524 -15.8% 20.00 US$490,480
2026-06-01 2026-06-01 S Sale Large shareholder
476 -0.4%
21.14
US$10,063
476 -0.4% 21.14 US$10,063
2026-06-01 2026-06-01 S Sale Large shareholder
24,524 -15.8%
20.00
US$490,480
24,524 -15.8% 20.00 US$490,480
2026-04-29 2026-04-29 PrS Proposed sale

10% Stockholder

Large shareholder
155,142
31.95
US$4,956,786
155,142 31.95 US$4,956,786
2026-05-15 2026-04-07 S Sale Large shareholder
1,108 -0.8%
33.38
US$36,985
1,108 -0.8% 33.38 US$36,985
2026-05-15 2026-04-07 S Sale Large shareholder
300 -0.2%
32.25
US$9,674
300 -0.2% 32.25 US$9,674
2026-05-15 2026-04-07 S Sale Large shareholder
4,423 -3.2%
31.38
US$138,813
4,423 -3.2% 31.38 US$138,813
2026-05-15 2026-04-07 S Sale Large shareholder
205 -0.2%
29.71
US$6,091
205 -0.2% 29.71 US$6,091
2026-05-15 2026-04-07 S Sale Large shareholder
2,115 -1.6%
28.94
US$61,212
2,115 -1.6% 28.94 US$61,212
2026-05-15 2026-04-07 B Purchase Large shareholder
1,108 +0.8%
33.38
US$36,985
1,108 +0.8% 33.38 US$36,985
2026-05-15 2026-04-06 S Sale Large shareholder
45 -0.0%
31.96
US$1,438
45 -0.0% 31.96 US$1,438
2026-05-15 2026-04-06 S Sale Large shareholder
1,214 -0.9%
31.02
US$37,662
1,214 -0.9% 31.02 US$37,662
2026-05-15 2026-04-06 B Purchase Large shareholder
1,104 +0.8%
31.02
US$34,246
1,104 +0.8% 31.02 US$34,246
2026-05-15 2026-04-02 S Sale Large shareholder
1,134 -0.8%
34.80
US$39,464
1,134 -0.8% 34.80 US$39,464
2026-05-15 2026-04-02 S Sale Large shareholder
374 -0.3%
33.35
US$12,472
374 -0.3% 33.35 US$12,472
2026-05-15 2026-04-02 S Sale Large shareholder
1,794 -1.2%
32.60
US$58,492
1,794 -1.2% 32.60 US$58,492
2026-05-15 2026-04-02 S Sale Large shareholder
1,265 -0.9%
31.75
US$40,165
1,265 -0.9% 31.75 US$40,165
2026-05-15 2026-04-02 S Sale Large shareholder
3,099 -2.1%
30.86
US$95,647
3,099 -2.1% 30.86 US$95,647
2026-05-15 2026-04-02 B Purchase Large shareholder
701 +0.5%
35.55
US$24,919
701 +0.5% 35.55 US$24,919
2026-05-15 2026-04-02 B Purchase Large shareholder
1,276 +0.9%
34.75
US$44,344
1,276 +0.9% 34.75 US$44,344
2026-05-15 2026-04-02 B Purchase Large shareholder
26 +0.0%
33.47
US$870
26 +0.0% 33.47 US$870
2026-05-15 2026-04-01 S Sale Large shareholder
46 -0.0%
34.75
US$1,598
46 -0.0% 34.75 US$1,598
2026-05-15 2026-04-01 S Sale Large shareholder
1,104 -0.7%
31.52
US$34,798
1,104 -0.7% 31.52 US$34,798
2026-05-15 2026-04-01 B Purchase Large shareholder
3,401 +2.4%
35.46
US$120,584
3,401 +2.4% 35.46 US$120,584
2026-05-15 2026-04-01 B Purchase Large shareholder
1,613 +1.1%
34.59
US$55,788
1,613 +1.1% 34.59 US$55,788
2026-05-15 2026-04-01 B Purchase Large shareholder
1,161 +0.8%
31.53
US$36,607
1,161 +0.8% 31.53 US$36,607
2026-05-15 2026-03-31 S Sale Large shareholder
87 -0.1%
31.52
US$2,742
87 -0.1% 31.52 US$2,742
2026-05-15 2026-03-31 S Sale Large shareholder
5 -0.0%
28.41
US$142
5 -0.0% 28.41 US$142
2026-05-15 2026-03-31 S Sale Large shareholder
57 -0.0%
27.11
US$1,546
57 -0.0% 27.11 US$1,546
2026-05-15 2026-03-31 S Sale Large shareholder
1,251 -0.8%
25.17
US$31,485
1,251 -0.8% 25.17 US$31,485
2026-05-15 2026-03-31 S Sale Large shareholder
191 -0.1%
24.28
US$4,638
191 -0.1% 24.28 US$4,638
2026-05-15 2026-03-31 B Purchase Large shareholder
411 +0.3%
32.60
US$13,397
411 +0.3% 32.60 US$13,397
2026-05-15 2026-03-31 B Purchase Large shareholder
1,957 +1.4%
31.45
US$61,550
1,957 +1.4% 31.45 US$61,550
2026-05-15 2026-03-31 B Purchase Large shareholder
186 +0.1%
30.48
US$5,668
186 +0.1% 30.48 US$5,668
2026-05-15 2026-03-31 B Purchase Large shareholder
17 +0.0%
27.78
US$472
17 +0.0% 27.78 US$472
2026-05-15 2026-03-31 B Purchase Large shareholder
1,048 +0.7%
26.73
US$28,009
1,048 +0.7% 26.73 US$28,009
2026-05-15 2026-03-31 B Purchase Large shareholder
1,770 +1.2%
25.32
US$44,818
1,770 +1.2% 25.32 US$44,818
2026-05-15 2026-03-31 B Purchase Large shareholder
616 +0.4%
24.69
US$15,206
616 +0.4% 24.69 US$15,206
2026-05-15 2026-03-30 S Sale Large shareholder
370 -0.3%
27.68
US$10,242
370 -0.3% 27.68 US$10,242
2026-05-15 2026-03-30 S Sale Large shareholder
518 -0.4%
25.85
US$13,390
518 -0.4% 25.85 US$13,390
2026-05-15 2026-03-30 B Purchase Large shareholder
370 +0.3%
27.68
US$10,242
370 +0.3% 27.68 US$10,242
2026-05-15 2026-03-30 B Purchase Large shareholder
1,176 +0.8%
26.70
US$31,399
1,176 +0.8% 26.70 US$31,399
2026-05-15 2026-03-30 B Purchase Large shareholder
4,995 +3.6%
25.99
US$129,820
4,995 +3.6% 25.99 US$129,820
2026-05-15 2026-03-30 B Purchase Large shareholder
2,992 +2.1%
25.08
US$75,035
2,992 +2.1% 25.08 US$75,035
2026-05-15 2026-03-27 S Sale Large shareholder
36 -0.0%
27.37
US$985
36 -0.0% 27.37 US$985
2026-05-15 2026-03-27 S Sale Large shareholder
469 -0.3%
26.77
US$12,553
469 -0.3% 26.77 US$12,553
2026-05-15 2026-03-27 B Purchase Large shareholder
294 +0.2%
28.13
US$8,270
294 +0.2% 28.13 US$8,270
2026-05-15 2026-03-27 B Purchase Large shareholder
4,384 +3.2%
27.28
US$119,607
4,384 +3.2% 27.28 US$119,607
2026-05-15 2026-03-27 B Purchase Large shareholder
10,643 +8.1%
26.29
US$279,840
10,643 +8.1% 26.29 US$279,840
2026-05-15 2026-03-26 S Sale Large shareholder
1,274 -1.0%
28.69
US$36,549
1,274 -1.0% 28.69 US$36,549